Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).
Stiehm ER, Fletcher CV, Mofenson LM, Palumbo PE, Kang M, Fenton T, Sapan CV, Meyer WA, Shearer WT, Hawkins E, Fowler MG, Bouquin P, Purdue L, Sloand EM, Nemo GJ, Wara D, Bryson YJ, Starr SE, Petru A, Burchett S. Stiehm ER, et al. Among authors: meyer wa. J Infect Dis. 2000 Feb;181(2):548-54. doi: 10.1086/315224. J Infect Dis. 2000. PMID: 10669338 Clinical Trial.
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Korelitz J, Meyer WA 3rd, Bethel J, Rich K, Pahwa S, Moye J Jr, Nugent R, Read J. Mofenson LM, et al. Among authors: meyer wa 3rd. J Infect Dis. 1997 May;175(5):1029-38. doi: 10.1086/516441. J Infect Dis. 1997. PMID: 9129063 Clinical Trial.
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group.
Lambert JS, Mofenson LM, Fletcher CV, Moye J Jr, Stiehm ER, Meyer WA 3rd, Nemo GJ, Mathieson BJ, Hirsch G, Sapan CV, Cummins LM, Jimenez E, O'Neill E, Kovacs A, Stek A. Lambert JS, et al. Among authors: meyer wa 3rd. J Infect Dis. 1997 Feb;175(2):283-91. doi: 10.1093/infdis/175.2.283. J Infect Dis. 1997. PMID: 9203648 Clinical Trial.
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Stiehm ER, Lambert JS, Mofenson LM, Bethel J, Whitehouse J, Nugent R, Moye J Jr, Glenn Fowler M, Mathieson BJ, Reichelderfer P, Nemo GJ, Korelitz J, Meyer WA 3rd, Sapan CV, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H. Stiehm ER, et al. Among authors: meyer wa 3rd. J Infect Dis. 1999 Mar;179(3):567-75. doi: 10.1086/314637. J Infect Dis. 1999. PMID: 9952362 Clinical Trial.
Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Harris DR, Rich K, Meyer WA 3rd, Read JS, Moye J Jr, Nugent RP, Korelitz J, Bethel J, Pahwa S. Mofenson LM, et al. Among authors: meyer wa 3rd. AIDS. 1999 Jan 14;13(1):31-9. doi: 10.1097/00002030-199901140-00005. AIDS. 1999. PMID: 10207542 Clinical Trial.
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ. Mofenson LM, et al. Among authors: meyer wa 3rd. N Engl J Med. 1999 Aug 5;341(6):385-93. doi: 10.1056/NEJM199908053410601. N Engl J Med. 1999. PMID: 10432323 Free article. Clinical Trial.
Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Read JS, Rich KC, Korelitz JJ, Mofenson LM, Harris R, Moye JH Jr, Meyer WA 3rd, Pahwa SG, Bethel JW, Nugent RP. Read JS, et al. Among authors: meyer wa 3rd. Pediatr Infect Dis J. 2000 Jun;19(6):544-51. doi: 10.1097/00006454-200006000-00011. Pediatr Infect Dis J. 2000. PMID: 10877171 Clinical Trial.
Progression of HIV disease among women following delivery.
Watts DH, Lambert J, Stiehm ER, Harris DR, Bethel J, Mofenson L, Meyer WA 3rd, Mathieson B, Fowler MG, Nemo G; PACTG 185 Study Team. Watts DH, et al. Among authors: meyer wa 3rd. J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):585-93. doi: 10.1097/00126334-200308150-00006. J Acquir Immune Defic Syndr. 2003. PMID: 12902802 Clinical Trial.
Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Read JS, Bethel J, Harris DR, Meyer WA 3rd, Korelitz J, Mofenson LM, Moye J Jr, Pahwa S, Rich K, Nugent RP. Read JS, et al. Among authors: meyer wa 3rd. Pediatr Infect Dis J. 1999 Feb;18(2):134-42. doi: 10.1097/00006454-199902000-00010. Pediatr Infect Dis J. 1999. PMID: 10048685
123 results